JP2012518598A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518598A5
JP2012518598A5 JP2011535742A JP2011535742A JP2012518598A5 JP 2012518598 A5 JP2012518598 A5 JP 2012518598A5 JP 2011535742 A JP2011535742 A JP 2011535742A JP 2011535742 A JP2011535742 A JP 2011535742A JP 2012518598 A5 JP2012518598 A5 JP 2012518598A5
Authority
JP
Japan
Prior art keywords
group
pyrimido
anticancer
alkyl group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011535742A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518598A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011535742A priority Critical patent/JP2012518598A/ja
Priority claimed from PCT/JP2010/052910 external-priority patent/WO2010098367A1/en
Publication of JP2012518598A publication Critical patent/JP2012518598A/ja
Publication of JP2012518598A5 publication Critical patent/JP2012518598A5/ja
Pending legal-status Critical Current

Links

JP2011535742A 2009-02-25 2010-02-18 ピリミドピリミドインダゾール誘導体 Pending JP2012518598A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011535742A JP2012518598A (ja) 2009-02-25 2010-02-18 ピリミドピリミドインダゾール誘導体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009042873 2009-02-25
JP2009042873 2009-02-25
PCT/JP2010/052910 WO2010098367A1 (en) 2009-02-25 2010-02-18 Pyrimidopyrimidoindazole derivative
JP2011535742A JP2012518598A (ja) 2009-02-25 2010-02-18 ピリミドピリミドインダゾール誘導体

Publications (2)

Publication Number Publication Date
JP2012518598A JP2012518598A (ja) 2012-08-16
JP2012518598A5 true JP2012518598A5 (https=) 2013-04-04

Family

ID=42665571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535742A Pending JP2012518598A (ja) 2009-02-25 2010-02-18 ピリミドピリミドインダゾール誘導体

Country Status (6)

Country Link
US (1) US8288396B2 (https=)
EP (1) EP2401281A4 (https=)
JP (1) JP2012518598A (https=)
AU (1) AU2010218781A1 (https=)
CA (1) CA2750716A1 (https=)
WO (1) WO2010098367A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017127088A (ru) 2010-11-16 2019-02-04 Эррэй Биофарма Инк. Комбинация ингибиторов чекпойнт-киназы 1 и ингибиторов киназы wee 1
DK2903440T3 (en) 2012-10-02 2017-12-11 Bayer Cropscience Ag THETEROCYCLIC COMPOUNDS AS PESTICIDES
FR3030513B1 (fr) * 2014-12-19 2016-12-23 Oreal Derives de benzoxazine cationiques et utilisation en coloration capillaire.
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
CN110678169A (zh) 2017-03-31 2020-01-10 西雅图遗传学公司 Chk1-抑制剂与weel-抑制剂的组合
AR111419A1 (es) 2017-04-27 2019-07-10 Novartis Ag Compuestos fusionados de indazol piridona como antivirales
EP3728266A1 (en) 2017-12-20 2020-10-28 Novartis AG Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
CN109912606B (zh) * 2019-04-16 2021-05-04 新乡医学院 一种嘧啶并吲唑类化合物的合成方法
BR112021026618A2 (pt) 2019-06-28 2022-06-07 Shanghai Pharmaceuticals Holding Co Ltd Composto de pirazolpirimidina, método de preparação do mesmo e aplicações do mesmo
CN112142748B (zh) 2019-06-28 2023-07-04 上海医药集团股份有限公司 一种吡唑酮并嘧啶类化合物、其制备方法及应用
US12551584B1 (en) 2020-12-07 2026-02-17 Actinium Pharmaceuticals, Inc. Lewis Y radioimmunotherapy for the treatment of cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5223608A (en) 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
FI931384A7 (fi) 1990-09-28 1993-03-26 Smithkline Beecham Corp Vesiliukoisia kamptotekiinianalogeja, prosesseja ja menetelmiä
US5200524A (en) 1990-12-20 1993-04-06 North Carolina State University Camptothecin intermediates and method of making same
US5247089A (en) 1990-12-20 1993-09-21 North Carolina State University Method of making intermediates useful for the manufacture of camptothecin and camptothecin analogs
US5191082A (en) 1990-12-20 1993-03-02 North Carolina State University Camptothecin intermediate and method of making camptothecin intermediates
US5243050A (en) 1990-12-20 1993-09-07 North Carolina State University Alkylpyridone DE ring intermediates useful for the manufacture of camptothecin and camptothecin analogs
US5162532A (en) 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
AU687727B2 (en) 1992-10-28 1998-03-05 Genentech Inc. Vascular endothelial cell growth factor antagonists
JP3025602B2 (ja) 1993-05-21 2000-03-27 デビオファーム エス.アー. 光学的に高純度なシス−オキザラート(トランス−l−1,2−シクロヘキサンジアミン)白金(II)錯体の製造方法
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
JP3154399B2 (ja) 1996-07-04 2001-04-09 デビオファーム エス.アー. 白金化合物の製造方法
TR200003429T2 (tr) * 1998-05-26 2001-07-23 Warner-Lambert Company Hücresel çoğalma inhibitörleri olarak bisiklik pirimidinler ve bisiklik 3,4-dihidropirimidinler.
US20040044012A1 (en) 1998-05-26 2004-03-04 Dobrusin Ellen Myra Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
WO2003091255A1 (en) 2002-04-26 2003-11-06 Warner-Lambert Company Llc Inhibitors of checkpoint kinases (wee1 and chk1)
US7094798B1 (en) 2002-04-26 2006-08-22 Pfizer Inc Inhibitors of checkpoint kinases (Wee1 and Chk1)
US20050250836A1 (en) 2004-05-03 2005-11-10 Pfizer Inc Inhibitors of checkpoint kinases (Wee1 and Chk1)
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP5129812B2 (ja) * 2007-06-15 2013-01-30 Msd株式会社 ビシクロアニリン誘導体

Similar Documents

Publication Publication Date Title
JP2012518598A5 (https=)
HRP20161536T1 (hr) Derivat bicikloanilina
TWI409262B (zh) 二氫吡唑并嘧啶酮衍生物
JP5411847B2 (ja) Weelキナーゼインヒビターとしてのジヒドロピラゾロピリミジノン誘導体の多形
CN107108588B (zh) 可用于治疗癌症的稠合双环(杂)芳香族化合物
JP2010525057A5 (https=)
JPWO2009054332A1 (ja) ピリドン置換ジヒドロピラゾロピリミジノン誘導体
WO2017087607A1 (en) Modulators of chemokine receptors
CA3150689A1 (en) Heterocyclic compounds as kinase inhibitors
JP5411152B2 (ja) オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
JP2012511501A (ja) ジヒドロピリミドピリミジン誘導体
JP2012529511A (ja) トリアジン誘導体類及びそれらの治療応用
JP2009515883A (ja) サイクリン依存性キナーゼ阻害剤としての新規イミダゾピラジン
WO2016042341A1 (en) Pyrrolcarboxamide derivatives for the inhbition of erk5
JP2018501209A5 (https=)
JP2018087200A (ja) 置換インドール−5−オール誘導体及びそれらの治療適用
CN102438626B (zh) 具有Aurora A选择性抑制作用的新型氨基吡啶衍生物
JP2012521426A (ja) オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
WO2023147015A1 (en) Substituted heterocyclic csnk1 inhibitors
AU2013337370B2 (en) Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
RU2007119776A (ru) Новые аминопиридиновые производные, обладающие селективной aurora a ингибирующей активностью